Clinical Studies Reporting on Vascular Graft Coatings for the Prevention of Aortic Graft Infection: A Systematic Review and Meta-Analysis
- PMID: 34801385
- DOI: 10.1016/j.ejvs.2021.09.020
Clinical Studies Reporting on Vascular Graft Coatings for the Prevention of Aortic Graft Infection: A Systematic Review and Meta-Analysis
Abstract
Objective: The aim of this study was to investigate the efficacy of vascular graft coatings used in the aortic position to prevent vascular graft infection (VGI).
Methods: A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines using a pre-registered protocol (CRD42020206436). Eligible studies used a vascular graft coating in the aortic position and reported on VGI. A search was performed in MEDLINE (PubMed), Embase, Web of Science, and the Cochrane Library. Primary outcome parameters were VGI, patency, and mortality. Pooled estimates of VGI were calculated using odds ratio (OR) and 95% confidence intervals (CIs) wherever possible. Quality assessment was performed with the Newcastle-Ottawa Assessment Scale and the Revised Cochrane risk of bias tool for randomised trials.
Results: In total, 6 873 papers were identified. Only eight studies were included. Six of eight studies (75%) reported on known antimicrobial coating strategies such as antibiotics (n = 3) and silver (n = 3). In the other two studies, polymer coated grafts were used. Only three of eight studies compared coated with uncoated grafts (two antibiotic and one silver). Two randomised controlled trials reported on the effect of rifampicin soaked (1 mg/mL) grafts and showed no significant effect in the early (2 months; OR 0.69, 95% CI 0.29 - 1.62) or late (2 years; OR 0.73, 95% CI 0.23 - 2.32) post-operative periods. A retrospective cohort study focusing on the effect of silver coated grafts did not reveal any advantage (OR 0.19, 95% CI 0.02 - 1.64). Two polymer coated grafts were not considered to have a potential benefit in the prevention of VGIs.
Conclusion: Clinical studies reporting on the antibacterial effect of vascular graft coatings in the aortic position to prevent VGI are scarce. For silver and antibiotic coatings, no significant protection for VGI was observed. New types of grafts or long acting coating strategies are mandatory to prevent this complication in the future.
Keywords: Aorta; Coating; Infection; Prevention; Vascular graft.
Copyright © 2021 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Pre-clinical In Vitro Models of Vascular Graft Coating in the Prevention of Vascular Graft Infection: A Systematic Review.Eur J Vasc Endovasc Surg. 2022 Jan;63(1):119-137. doi: 10.1016/j.ejvs.2021.07.015. Epub 2021 Oct 19. Eur J Vasc Endovasc Surg. 2022. PMID: 34674936
-
Pre-clinical in vivo Models of Vascular Graft Coating in the Prevention of Vascular Graft Infection: A Systematic Review.Eur J Vasc Endovasc Surg. 2021 Jul;62(1):99-118. doi: 10.1016/j.ejvs.2021.02.054. Epub 2021 Apr 9. Eur J Vasc Endovasc Surg. 2021. PMID: 33840577
-
Is silver still the Holy Grail for vascular grafts?J Cardiovasc Surg (Torino). 2023 Jun;64(3):304-309. doi: 10.23736/S0021-9509.22.12538-3. Epub 2022 Dec 19. J Cardiovasc Surg (Torino). 2023. PMID: 36534125 Review.
-
A systematic review of preclinical data regarding commercial silver-coated vascular grafts.J Vasc Surg. 2021 Oct;74(4):1386-1393.e1. doi: 10.1016/j.jvs.2021.04.055. Epub 2021 May 19. J Vasc Surg. 2021. PMID: 34019984
-
Efficacy of collagen silver-coated polyester and rifampin-soaked vascular grafts to resist infection from MRSA and Escherichia coli in a dog model.Ann Vasc Surg. 2008 Nov;22(6):815-21. doi: 10.1016/j.avsg.2008.06.011. Epub 2008 Oct 2. Ann Vasc Surg. 2008. PMID: 18835516
Cited by
-
Bioengineering Human Tissues and the Future of Vascular Replacement.Circ Res. 2022 Jun 24;131(1):109-126. doi: 10.1161/CIRCRESAHA.121.319984. Epub 2022 Jun 23. Circ Res. 2022. PMID: 35737757 Free PMC article. Review.
-
Versatile Polycaprolactone-Based Drug Delivery System with Enhanced Cytocompatibility and Antibacterial Activity.J Funct Biomater. 2025 May 15;16(5):182. doi: 10.3390/jfb16050182. J Funct Biomater. 2025. PMID: 40422846 Free PMC article.
-
Implant Infectious Diseases: An Introduction to Biomaterials for ID Physicians.Open Forum Infect Dis. 2025 Jul 12;12(8):ofaf411. doi: 10.1093/ofid/ofaf411. eCollection 2025 Aug. Open Forum Infect Dis. 2025. PMID: 40756651 Free PMC article. Review.
-
Enhanced antimicrobial efficacy by impregnation of vascular grafts with nanocolloidal silver.JVS Vasc Sci. 2025 Apr 10;6:100286. doi: 10.1016/j.jvssci.2025.100286. eCollection 2025. JVS Vasc Sci. 2025. PMID: 40511342 Free PMC article.
-
Electrospun Chitosan-Based Nanofibrous Coating for the Local and Sustained Release of Vancomycin.ACS Omega. 2024 Feb 28;9(10):11701-11717. doi: 10.1021/acsomega.3c08113. eCollection 2024 Mar 12. ACS Omega. 2024. PMID: 38496925 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical